A Study to Evaluate the Efficacy and Safety of CREZET Tablet

NCT05889143 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

15000

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: Ezetimibe/Rosuvastatin

Sponsor

Daewoong Pharmaceutical Co. LTD.